Markets
IBB

Biotechnology and Home Construction: 2 ETFs to Watch on Outsized Volume

In the last trading session, U.S. stocks dipped on weak profit data from China. As for the top ETFs, investors saw SPY lose 2.5%, DIA shed 1.9%, while QQQ moved lower by 2.8% on the day.

Two more specialized ETFs are worth noting in particular as both saw trading volume far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch in the days ahead to see if this trend of extra-interest continues:

IBB : Volume 5.6 times average

This biotechnology ETF was in focus yesterday as around 11.8 million shares moved hands on the day compared to an average of roughly 2.1 million shares. We also saw some share price movement as shares of IBB fell 6.3% yesterday.

This was the worst trading day performance of the ETF in more than four years. The plunge was driven by a huge sell-off in biotech stocks that we find in this ETF portfolio as Democratic lawmakers severely criticized huge price increases of two heart drugs by Canada's Valeant Pharmaceuticals International, Inc. ( VRX ). For the past one month, IBB went down 15%. The fund currently has a Zacks ETF Rank #2 (Buy) with a High risk outlook.

ITB : Volume 3.1 times average

This home construction ETF was in the spotlight as roughly 11.3 million shares moved hands yesterday compared to an average of roughly 3.7 million shares. ITB dropped 4.4% in the session.

The move can largely be blamed on data indicating a more-than-expected decline in pending home sales in August affecting the homebuilding stocks that we find in this ETF portfolio. ITB slid 5.7% in the past one month and it currently has a Zacks ETF Rank #2 with a High risk outlook.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SPDR-SP 500 TR (SPY): ETF Research Reports

SPDR-DJ IND AVG (DIA): ETF Research Reports

NASDAQ-100 SHRS (QQQ): ETF Research Reports

VALEANT PHARMA (VRX): Free Stock Analysis Report

ISHARES NDQ BIO (IBB): ETF Research Reports

ISHARS-US HO CO (ITB): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

IBB DIA SPY QQQ

Other Topics

ETFs

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More